homepee.com

ÇÐȸ ¹× ÈÄ¿ø

ÇÐȸ ¹× ÈÄ¿ø

¡å

  • CUSTOMER
  • 02-3425-1139
  • am 08:00 ~ pm 06:00
¿Â¶óÀι®ÀÇ
  • Home
  • ÇÐȸ ¹× ÈÄ¿ø
  • ICNIM

ICNIMÇÐȸ ¹× ÈÄ¿ø

Á¦¸ñ Á¦23ȸ ICNIM2015
ÀÛ¼ºÀÚ KCFKOREA
ÀÛ¼ºÀÏÀÚ 2019-04-09



 




Á¦23ȸ ÅëÇÕÀÇ·á ±â´É¼º ½ÄÇ° ±¹Á¦ ȸÀÇ(ICNIM2015)

³¯Â¥ : 2015³â 7¿ù 25ÀÏ(Åä)~26ÀÏ(ÀÏ)

Àå¼Ò : »ñÆ÷·Î½Ã(·ÎÀÌÆ° »ñÆ÷·Î)

ÁÖÃÖ : AHCC¿¬±¸È¸

ÈÄ¿ø : °æÁ¦ »ê¾÷¼º ȪīÀ̵µ °æÁ¦ »ê¾÷±¹, ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷È­ÇÐ



 




 Á¦23ȸ ÅëÇÕÀÇ·á ±â´É¼º ½ÄÇ° ±¹Á¦È¸ÀÇ(ICNIM2015)°¡ ÀϺ» »ñÆ÷·Î¿¡¼­ °³ÃֵǾú½À´Ï´Ù.
ÅëÇÕÀÇ·á ±â´É¼º ½ÄÇ° ±¹Á¦È¸ÀÇ ICNIMÀº AHCC ¿¬±¸È¸°¡ ÁÖÃÖÇÏ°í ÀϺ» ȪīÀ̵µ °æÁ¦»ê¾÷±¹,

 ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷È­ÇÐÀÌ ÈÄ¿øÇÕ´Ï´Ù.


¿ÃÇØ´Â ¾à 20°³±¹ 400¿© ¸íÀÇ ÀÇ·á°ü°èÀÚ°¡ Âü¼®ÇÏ¿© AHCC, Oligonol, ETAS µî

´Ù¾çÇÑ ¿ø·á¸¦ °¡Áö°í ÀÓ»ó½ÃÇè º¸°í, Åä·Ð¹ßÇ¥¸¦ Çϸç ÀÇ¹Ì ÀÖ´Â ½Ã°£À» °¡Á³½À´Ï´Ù.


 

À̹ø ICNIM2015 ¿©´Â ±âÁ¶°­¿¬Àº µµÄì´ë ÀÇ°úÇÐ ¿¬±¸¼ÒÀÇ  ¼¼À̳ë È÷·Î½Ã ±³¼ö°¡
"Àå³» ȯ°æ°ú ¸é¿ª¿¡ ÀÇÇÑ °Ç°­°ú Áúº´ Á¦¾î"
"Intestinal Environment and Immunity for Health and Diseases"¶ó´Â Á¦¸ñÀ» °¡Áö°í °­¿¬À» ÇÏ¿´½À´Ï´Ù.

ÀåÀº ¸é¿ª·Â°ú ¹ÐÁ¢ÇÑ °ü°è¸¦ °¡Áö¸ç ¿¬¼Ó¼ºÀ» °¡Áý´Ï´Ù.

¶ÇÇÑ, Àå°ü¸é¿ªÀº Àü ¼¼°èÀûÀ¸·Î °ü½ÉÀ» °¡Áö´Â ÁÖÁ¦·Î ICNIM2015¿¡ Âü¼®ÇÑ °ü°èÀÚµéÀÇ ¸¹Àº °ü½ÉÀ» ¹Þ¾Ò½À´Ï´Ù.


¿ÃÇØ´Â ¸é¿ª·Â¿¡ °üÇÑ ÀÓ»ó¹ßÇ¥,
½ÇÇè ¹ßÇ¥°¡ ¸¹¾Æ ¸é¿ª¿¡ ´ëÇÑ Á߿伺À» ´Ù½Ã Çѹø ´À³¥ ¼ö ÀÖ´Â ÀÚ¸®¿´½À´Ï´Ù.
 





Keynote Lecture


¡°Intestinal environment and immunity for health and diseases¡±
Hiroshi Kiyono (The University of Tokyo)


General Lecture


¡°Rare sugars in NO-suppressive fractions from AHCC
¡°Kenji Sato (Kyoto University)

¡°AHCC mediates lymphocyte activation and promotes cell adhesion via direct targeting of T cell receptors and adhesion molecules¡±
Alamelu Sundaresan (Texas Southern University)

¡°Suppression of mouse and human cancer by AHCC¡±
Taisei Nomura (National Institute of Biomedical Innovation)

¡°The efficacy and safety of AHCC for pulmonary non-tuberculous mycobacteriosis¡±
Masaki Fujita (Fukuoka University Hospital)

¡°AHCC for potential treatment of high risk HPV infections¡±
Judith A. Smith (The University of Texas Health Science Center Medical School at Houston)

¡°The effect of AHCC addition to long-term oral antiviral agents (OAA) treatment on HBsAg level in patients with CHBeAg negative¡±
Anuchit Chutaputti (Phramongkutklao Hospital)

¡°Enzyme-Treated Asparagus Extract attenuates hydrogen peroxide-induced matrix metalloproteinase-9 expression in murine dermal fibroblast L929¡±
Ken Shirato (Kyorin University)

¡°Effect of Enzyme-Treated Asparagus Extract on cerebral blood volume in frontal cortex under psychological stress¡±
Hideaki Waki (Teikyo Heisei University)

¡°Oligonol protects against palmitate-induced senescence and insulin resistance in C2C12 muscle cells and promotes survival and prevents muscle atrophy in obese diabetic (db/db) mice¡±
Sue-Joan Chang (National Cheng Kung University)

¡°Oligonol supplementation contributes to improved patient outcomes when incorporated into an integrative weight loss regimen¡±
Jaime Salas Rushford (Anti-Aging Medicine & Nshape Medicine)

¡°Study on stable supercooling-promoting activity of water by Oligonol¡±
Seizo Fujikawa (Hokkaido University)

¡°Regulatory effects of Oligonol, Perilla and AHCC on human immune cells¡±
Insoo Kang (Yale University)

¡°Molecular mechanisms underlying protective effects of the formulated extract of Perilla frutescens (L.) on experimentally induced murine colitis mimicking human inflammatory bowel disease¡±
Young-Joon Surh (Seoul National University)

¡°Evaluation of the anti-inflammatory effects of functional foods using primary cultured rat hepatocytes¡±
Mikio Nishizawa (Ritsumeikan University)

¡°The case of long-term survival patients who rejected the operation and were treated with AHCC alone – Role of AHCC on the terminal stage of cancers -¡°
Yusai Kawaguchi (Ichiyukai Fujimoto Hospital)

¡°AHCC clinical results follow up¡±
Francisco J. Karkow (Fatima¡¯s Faculty)

¡°The use of AHCC in integrated oncology therapy: new cases and new work projects¡±
Massimo Bonucci (San Feliciano Hospital)

¡°Effects of Lilac LABR on bowel movement and fecal properties of healthy volunteers with a tendency for constipation¡±
Kimiko Minamida (Arterio Bio Co., Ltd.)

¡°Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment¡±
Asuka Yasueda (Osaka University)


Poster Session


¡°Inhibitory effect of Enzyme-Treated Asparagus Extract on a murine model of experimental colitis¡±
Yumiko Yasui (Rakuno Gakuen University)

¡°Protective effects of Enzyme-Treated Asparagus Extract (ETAS) on ultraviolet radiation induced damaged skin¡±
Tomoko Koda (Tokyo Healthcare University)

¡°Protective role of ETAS uptake against side effects of chemotherapeutic drugs¡±
Yuiko Hashino (Sapporo Medical University)

¡°Establishment of the phase I trial methodology in the dietary supplement – A report of phase I and II clinical study of Enzyme-Treated Asparagus Extract (ETAS) -¡°
Miki Sakaue (Osaka University)

¡°Estimating efficacy of Enzyme-Treated Asparagus Extract (ETAS) therapy in elderly patients with mild and moderate cognitive disorders¡±
Natalia V. Mikhailichenko (NEVRON International Medical Center)

¡°New model of integrative medicine from Korea: Brain and nutrition¡±
Seung Wan Kang (Seoul National University)

¡°AHCC modifies the intestinal settlement of T. spiralis after an antibiotic treatment¡±
Juan J. Garcia-Rodriguez (Complutense University of Madrid)

¡°AHCC treatment reduces weight loss, rectal bleeding and intestinal permeability alterations in DSS-induced colitis in CD1 mice¡±
Juan A. Rodriguez-Feo (Gregorio Maranon Hospital)

¡°Oral administered AHCC moderates LPS-induced hypotensive response and gut injury in rats¡±
Marie-Francoise Doursout (University of Texas Medical School at Houston)

¡°Effect of AHCC in women receiving adjuvant chemotherapy for breast cancer: Accomplishments and future directions¡±
Satoru Iwase (The University of Tokyo)

¡°Role of selenium in CHB patients on combination treatment with OAA (oral antiviral agents) and AHCC¡±
Anuchit Chutaputti (Phramongkutklao Hospital)

¡°Prospects for cooperation and implementation of AHCC into clinical practice in the Republic of Kazakhstan¡±
Zhangentkhan Abylaiuly (Asfendiyarov Kazakh National Medical University)

¡°Down-regulation of HSF1 in pancreatic cells by AHCC-treatment in vitro¡±
Yasuhiro Kuramitsu (Yamaguchi University)

¡°The effects of AHCC on the expression of SOX2 in inflammation-induced tumor progression model cells¡±
Masayuki Tokunaga (Yamaguchi University)

¡°Effects of AHCC on regulatory roles of natural antisense RNA for human breast cancer¡±
Ryou Sakamoto (Ritsumeikan University)

¡°Anti-diabetic and anti-Alzheimer effects of Oligonol¡±
Jae Sue Choi (Pukyong National University)

¡°Hypolipidemic effect of orally administrated Oligonol in rats fed diet with lard¡±
Kyoichi Osada (Meiji University)

¡°Effects of Oligonol on high glucose-induced inflammatory responses in endothelial cells¡±
Yoshimi Kishimoto (Ochanomizu University)

¡°Anti-inflammatory activity of high Oligonol content candy with anti-oral candidiasis properties¡±
Kazumi Hayama (Teikyo University Institute of Medical Mycology)

¡°Effects of soy isoflavones on bone resorption in middle aged women¡±
Fumio Namba (Fujicco Co. Ltd.)

¡°Perilla leaf extract prevents atopic dermatitis induced by Dermatophagoides farinae extract in NC/Nga mouse¡±
Koji Wakame (Hokkaido Pharmaceutical University)

¡°The effect of perilla on the macrophage activation¡±
Emi Saita (Ochanomizu University)

¡°Glutamic acid has a liver-protective effect through the suppression of inducible nitric oxide synthase in ¡°in vitro liver injury model¡±¡±
Richi Nakatake (Kansai Medical University)

¡°Rapid in vivo-like phenotypic assay of epidermis pro-turnover efficacy with toxicity by gold kiwi fruit grown in Saga prefecture, Japan¡±
Toshihiro Ona (Kyushu University)







Á¶È¸¼ö 340

INFORMATION
  • ȸ»ç¸í : ÄÉÀ̾¾¿¡ÇÁÄÚ¸®¾Æ
  • ´ëÇ¥ÀÚ¸í : ±è°ÇÁ¾
  • ÁÖ¼Ò : ¼­¿ï½Ã ±¤Áø±¸ ¶Ò¼¶·Î 700, 202È£
  • ´ëÇ¥ÀüÈ­ : 02-3425-1139
  • ´ëÇ¥ÀüÈ­ : 02-3425-1139
LICENCE
  • »ç¾÷ÀÚµî·Ï¹øÈ£ : 220-81-86504
WEB MASTER
  • e-mail : customer@kcfkorea.com
  • °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ Ã¥ÀÓÀÚ : ±è¸íÈñ
SITEMAP
¸ðµç ÄÁÅÙÃ÷ÀÇ ¹«´ÜÀüÁ¦ ¹× ¸µÅ©¸¦ ±ÝÁöÇÕ´Ï´Ù.
Copyright(c) 1989 by KCFKOREA All Rights Reserved. Designed by www.raphaheal.com